For the quarter ending 2025-09-30, LPCN has $16,073,167 in assets. $1,931,119 in debts. $3,901,040 in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 3,901,040 | 6,043,980 | ||
| Marketable investment securities | 11,230,031 | 11,891,702 | ||
| Accrued interest income | 115,272 | 121,732 | ||
| Prepaid and other current assets | 683,797 | 362,629 | ||
| Total current assets | 15,930,140 | 18,420,043 | ||
| Property and equipment, net of accumulated depreciation of 1,269,098 and 1,223,297 respectively | 119,274 | 133,397 | ||
| Other assets | 23,753 | 23,753 | ||
| Total assets | 16,073,167 | 18,577,193 | ||
| Accounts payable | 861,452 | 442,994 | ||
| Accrued expenses | 749,667 | 685,779 | ||
| Deferred revenue | 320,000 | 320,000 | ||
| Total current liabilities | 1,931,119 | 1,448,773 | ||
| Total liabilities | 1,931,119 | 1,448,773 | ||
| Common stock, par value 0.0001 per share, 75,000,000 shares authorized 5,420,592 and 5,348,276 issued and 5,420,256 and 5,347,940 outstanding, respectively | 8,870 | 8,865 | ||
| Additional paid-in capital | 221,195,546 | 221,000,961 | ||
| Treasury stock at cost, 336 shares | 40,712 | 40,712 | ||
| Accumulated other comprehensive income | 4,627 | -1,243 | ||
| Accumulated deficit | -207,026,283 | -203,839,451 | ||
| Total stockholders equity | 14,142,048 | 17,128,420 | ||
| Total liabilities and stockholders equity | 16,073,167 | 18,577,193 | ||
Lipocine Inc. (LPCN)
Lipocine Inc. (LPCN)